These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

529 related items for PubMed ID: 12884068

  • 21.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 22.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 23.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 24. Development of candidemia on caspofungin therapy: a case report.
    Cheung C, Guo Y, Gialanella P, Feldmesser M.
    Infection; 2006 Dec; 34(6):345-8. PubMed ID: 17180591
    [Abstract] [Full Text] [Related]

  • 25. Epidemiology and outcomes of candidemia in 2019 patients: data from the prospective antifungal therapy alliance registry.
    Horn DL, Neofytos D, Anaissie EJ, Fishman JA, Steinbach WJ, Olyaei AJ, Marr KA, Pfaller MA, Chang CH, Webster KM.
    Clin Infect Dis; 2009 Jun 15; 48(12):1695-703. PubMed ID: 19441981
    [Abstract] [Full Text] [Related]

  • 26. Treatment of Candida glabrata infection in immunosuppressed mice by using a combination of liposomal amphotericin B with caspofungin or micafungin.
    Olson JA, Adler-Moore JP, Smith PJ, Proffitt RT.
    Antimicrob Agents Chemother; 2005 Dec 15; 49(12):4895-902. PubMed ID: 16304150
    [Abstract] [Full Text] [Related]

  • 27.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 28.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 29.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 30. Invasive candidiasis in intensive care units in China: in vitro antifungal susceptibility in the China-SCAN study.
    Liu W, Tan J, Sun J, Xu Z, Li M, Yang Q, Shao H, Zhang L, Liu W, Wan Z, Cui W, Zang B, Jiang D, Fang Q, Qin B, Qin T, Li W, Guo F, Liu D, Guan X, Yu K, Qiu H, Li R, China-SCAN team.
    J Antimicrob Chemother; 2014 Jan 15; 69(1):162-7. PubMed ID: 24004860
    [Abstract] [Full Text] [Related]

  • 31. Epidemiology and antifungal susceptibility of Candida species isolated from blood: results of a 2-year multicentre study in Spain.
    Pemán J, Cantón E, Gobernado M, Spanish ECMM Working Group on Candidaemia.
    Eur J Clin Microbiol Infect Dis; 2005 Jan 15; 24(1):23-30. PubMed ID: 15619060
    [Abstract] [Full Text] [Related]

  • 32.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 33. New options for treatment of candidaemia in critically ill patients.
    Ruhnke M, Hartwig K, Kofla G.
    Clin Microbiol Infect; 2008 May 15; 14 Suppl 4():46-54. PubMed ID: 18430129
    [Abstract] [Full Text] [Related]

  • 34.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 35.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 36.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 37. [Comparison of broth microdilution and E-test methods for the antifungal susceptibility testing of Candida spp. strains isolated from blood cultures].
    Ozcan SK, Mutlu B, Dündar D, Willke A.
    Mikrobiyol Bul; 2010 Apr 15; 44(2):263-71. PubMed ID: 20549961
    [Abstract] [Full Text] [Related]

  • 38.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 39. Distribution and antifungal susceptibility of Candida species causing candidemia from 1996 to 1999.
    Cheng MF, Yu KW, Tang RB, Fan YH, Yang YL, Hsieh KS, Ho M, Lo HJ.
    Diagn Microbiol Infect Dis; 2004 Jan 15; 48(1):33-7. PubMed ID: 14761719
    [Abstract] [Full Text] [Related]

  • 40.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 27.